Expert Interview
Investigating the topline results from the phase 3 study 501 on Lumateperone as an adjunctive therapy for major depressive disorder.
Ticker(s): ITCIInstitution: University of Minnesota
- Interventional Psychiatrist and Assistant Professor with the Department of Psychiatry for the University of Minnesota Medical School.
- Manages 80 patients with treatment resistant depression and has personally treated 40-50 psychiatric DBS patients, including patients who have been in Abbott's prior BROADEN trial.
- Research interests include deep brain stimulation, vagus nerve stimulation and transcranial magnetic stimulation and has written numerous review articles on these topics.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
